$79.83
-1.22-1.51%
At close: -
$80.20
0.370.46%
After Hours: Jun 13, 7:52 PM EDT
Comments
Loading...
Latest Novo Nordisk Stock News | NYSE:NVO | Benzinga
Get the latest news on Novo Nordisk stock with updates on market trends, financials, and analysis from Benzinga. Stay informed on Novo Nordisk performance
Categories: All
Friday, June 13, 2025
Thursday, June 12, 2025
Wednesday, June 11, 2025
Tuesday, June 10, 2025
Monday, June 09, 2025
Friday, June 06, 2025
Thursday, June 05, 2025
Tuesday, June 03, 2025
Monday, June 02, 2025
Friday, May 30, 2025
Wednesday, May 28, 2025
Tuesday, May 27, 2025
Friday, May 23, 2025
Thursday, May 22, 2025
Tuesday, May 20, 2025
Monday, May 19, 2025
Friday, May 16, 2025
Wednesday, May 14, 2025
Tuesday, May 13, 2025
Monday, May 12, 2025
- Novo Nordisk's Sogroya Supports Effective Weekly Alternative To Daily Hormone Therapy Across Three Growth Disorders
- Mark Cuban Slams Charlie Kirk Over Drug Price Debate, Says PBMs — Not Big Pharma — Are The Real Villains: 'For Your Company…Ask Your PBM For A List Of Claims'
- Novo Nordisk Presented Data From Phase 3 REAL...
- Trump's New Drug Pricing Executive Order Could Rattle Pharma Stocks, With Price Cuts Of Up To 80%: Novo Nordisk, Pfizer And J&J Fall In Premarket
- Eli Lilly's Zepbound Shows Superior Weight Loss Over Novo Nordisk's Wegovy In Head-To-Head Trial
- Trump Says Prescription Drug Prices Set To Drop By 30% To 80% 'Almost Immediately' Thanks To 'Most Favored Nation' Plan, Mark Cuban Urges President To 'Force Transparency'
